Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02453659 · ClinicalTrials.gov registry record · NA
Women Engaging in Quitting Smoking Together
A NA study, sponsored by Rhode Island Hospital.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT02453659: Completed NA study, sponsored by Rhode Island Hospital.
NCT02453659 is a NA study that has completed, run by Rhode Island Hospital. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02453659, a NA study, has completed, sponsored by Rhode Island Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The long-term goal of this program of research is to develop and disseminate an efficacious, group-based distress tolerance treatment for weight concern (DT-W) that will significantly increase smoking cessation rates among women. The objective of this project is to conduct a preliminary randomized controlled trial (RCT) (N = 60) comparing DT-W to a Health Education (HE) comparison intervention, in which both groups also receive standard behavioral smoking cessation treatment (ST) including counseling and transdermal nicotine patch (TNP), and examine potential mechanisms that may underlie the efficacy of DT-W in improving smoking outcomes at 1-, 3-, and 6-month follow-ups.
Primary Outcome
The investigators will compare the percentage of participants in each treatment group who report abstinence from smoking for the 7 days prior to each follow-up assessment (1-, 3-, and 6-months post-quit date).
Interventions
- DRUG Transdermal Nicotine Patch
- BEHAVIORAL Health Education (HE)
- BEHAVIORAL Distress Tolerance Treatment for Weight Concern (DT-W)
- BEHAVIORAL Smoking Cessation counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-05 |
| Est. Completion | 2018-12 |
| Phase | NA |
What the finished NCT02453659 record still lists
NCT02453659 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 4 interventions - of which Transdermal Nicotine Patch is the first listed.
NCT02453659 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02453659 about?
NCT02453659 is a clinical study titled "Women Engaging in Quitting Smoking Together". The long-term goal of this program of research is to develop and disseminate an efficacious, group-based distress tolerance treatment for weight concern (DT-W) that will significantly increase smoking cessation rates among women. The objective of this project is to conduct a preliminary randomized c...
What is the current status of trial NCT02453659?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2015-05. Estimated completion is 2018-12.
What interventions are being tested in trial NCT02453659?
The interventions under investigation include: Transdermal Nicotine Patch (DRUG), Health Education (HE) (BEHAVIORAL), Distress Tolerance Treatment for Weight Concern (DT-W) (BEHAVIORAL), Smoking Cessation counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT02453659?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02453659's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia